We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+26.9%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$34.9M
Cap. Flow
+$7.29M
Cap. Flow %
3.61%
Top 10 Hldgs %
43.02%
Holding
86
New
26
Increased
16
Reduced
19
Closed
17

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$10.7M
2
AET
Aetna Inc
AET
+$6.28M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.94M
4
CAH icon
Cardinal Health
CAH
+$2.36M
5
JUNO
Juno Therapeutics, Inc.
JUNO
+$2.14M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$7.07M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.48M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.09M
4
ELV icon
Elevance Health
ELV
+$2.88M
5
MZOR
Mazor Robotics Ltd.
MZOR
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 66.28%
2 Financials 3.15%
3 Energy 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$12.2M 6.05%
250,000
-25,000
-9% -$1.14M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$11.8M 5.83%
+50,000
New +$11.6M
CELG
3
DELISTED
Celgene Corp
CELG
$11.2M 5.54%
90,000
+10,000
+13% +$1.2M
SHPG
4
DELISTED
Shire pic
SHPG
$10.7M 5.28%
+61,250
New +$10.7M
AMGN icon
5
Amgen
AMGN
$208B
$8.2M 4.06%
50,000
– –
MRK icon
6
Merck
MRK
$322B
$7.94M 3.93%
131,000
+15,720
+14% +$954K
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7.37M 3.65%
200,000
+25,000
+14% +$630K
AET
8
DELISTED
Aetna Inc
AET
$6.38M 3.15%
+50,000
New +$6.28M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$6.06M 3%
50,000
-5,000
-9% -$645K
GKOS icon
10
Glaukos
GKOS
$9.83B
$5.13M 2.54%
100,000
-20,000
-17% -$872K
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$2.45B
$5.08M 2.51%
75,000
-85,000
-53% -$6.48M
DERM
12
DELISTED
Dermira, Inc.
DERM
$4.78M 2.36%
140,000
-10,000
-7% -$323K
OMED
13
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4.51M 2.23%
490,000
-60,000
-11% -$527K
MRUS
14
DELISTED
Merus
MRUS
$4.27M 2.11%
175,000
+25,000
+17% +$638K
AGN
15
DELISTED
Allergan plc
AGN
$4.18M 2.07%
17,500
+5,000
+40% +$1.16M
KTWO
16
DELISTED
K2M Group Holdings, Inc
KTWO
$4.1M 2.03%
200,000
+50,000
+33% +$1.03M
AERI
17
DELISTED
Aerie Pharmaceuticals
AERI
$3.85M 1.91%
85,000
-30,000
-26% -$1.34M
KPTI icon
18
Karyopharm Therapeutics
KPTI
$43.5M
$3.53M 1.75%
+18,333
New +$2.94M
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$3.18M 1.57%
50,000
-25,000
-33% -$1.52M
ABT icon
20
Abbott
ABT
$183B
$3.11M 1.54%
70,000
-45,000
-39% -$1.95M
ALXN
21
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$3.03M 1.5%
+25,000
New +$3.22M
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
$2.99M 1.48%
40,000
-30,000
-43% -$2.18M
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
$2.91M 1.44%
35,000
– –
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.59B
$2.82M 1.39%
90,000
-10,000
-10% -$268K
BIIB icon
25
Biogen
BIIB
$30B
$2.73M 1.35%
10,000
-25,000
-71% -$7.07M
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2017 Portfolio in Review

As of Q1 2017, Iguana Healthcare Management held 86 positions worth $202M, up 21% from $167M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $7.29M of net new capital in Q1 2017, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was Shire pic: 61,250 shares worth $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 76% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Biogen, an estimated $7.07M trimmed.

  • Iguana Healthcare Management's largest Q1 2017 buy was Shire pic: 61,250 shares worth $10.7M.
  • Iguana Healthcare Management added most to Celgene Corp in Q1 2017, an estimated $1.2M increase.
  • Iguana Healthcare Management's biggest Q1 2017 reduction was Biogen, cutting an estimated $7.07M.
  • Iguana Healthcare Management fully exited Elevance Health in Q1 2017, selling an estimated $2.88M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $202M portfolio in Q1 2017.
  • Iguana Healthcare Management opened 26 new positions and closed 17 in Q1 2017.
  • Iguana Healthcare Management's portfolio value rose 21% quarter-over-quarter to $202M.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.